+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical Fermentation System Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989649
  • Report
  • July 2021
  • Region: Global
  • 182 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Biopharmaceutical Fermentation System Market will Grow to USD 19.58 Billion by 2026, at a CAGR of 7.63%

FEATURED COMPANIES

  • Becton
  • Danaher Corporation
  • Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Lonza
  • MORE
The Global Biopharmaceutical Fermentation System Market size was estimated at USD 12.59 Billion in 2020 and expected to reach USD 13.51 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 7.63% to reach USD 19.58 Billion by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biopharmaceutical Fermentation System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Biopharmaceutical Fermentation System Market was examined across Downstream Process Product and Upstream Process Product. The Downstream Process Product was further studied across Chromatography Systems, Consumables and Accessories, and Filtration and Separation Instruments. The Upstream Process Product was further studied across Bioreactors/Fermenters, Buffers, Media and Culture Preparation, and Process Monitoring Systems.
  • Based on Application, the Biopharmaceutical Fermentation System Market was examined across Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins.
  • Based on End User, the Biopharmaceutical Fermentation System Market was examined across Biopharmaceutical Companies, Contract Research Organizations, Food Industry, and Research and Development Institutes.
  • Based on Geography, the Biopharmaceutical Fermentation System Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceutical Fermentation System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceutical Fermentation System Market, including Becton, Danaher Corporation, Dickinson and Company, F. Hoffmann-La Roche Ltd, GE Healthcare, Lonza, Merck KGaA, Nova Biomedicals, Sartorius Stedim, and Thermo Fisher Scientific.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceutical Fermentation System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Fermentation System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Fermentation System Market?
4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Fermentation System Market?
5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Fermentation System Market?
6. What is the market share of the leading vendors in the Global Biopharmaceutical Fermentation System Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Fermentation System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Becton
  • Danaher Corporation
  • Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Lonza
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biotech based drugs
5.1.1.2. Increasing incidences of chronic diseases
5.1.1.3. Rising demand for recombinant drugs or biopharmaceuticals such as proteins, enzymes
5.1.1.4. Development in industrial measurement and monitoring technologies for bio-based production processes
5.1.2. Restraints
5.1.2.1. High cost related with the manufacturing and stringent regulatory requirements
5.1.3. Opportunities
5.1.3.1. Innovations in the production of novel biological drugs
5.1.3.2. New innovations to make efficient and cost-effective fermentation systems
5.1.3.3. Increasing research and developmental activities in different fields of fermentation technology
5.1.4. Challenges
5.1.4.1. Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Biopharmaceutical Fermentation System Market, by Product
6.1. Introduction
6.2. Downstream Process Product
6.2.1. Chromatography Systems
6.2.2. Consumables and Accessories
6.2.3. Filtration and Separation Instruments
6.3. Upstream Process Product
6.3.1. Bioreactors/Fermenters
6.3.2. Buffers
6.3.3. Media and Culture Preparation
6.3.4. Process Monitoring Systems

7. Biopharmaceutical Fermentation System Market, by Application
7.1. Introduction
7.2. Antibiotics
7.3. Monoclonal Antibodies
7.4. Probiotics
7.5. Recombinant Proteins

8. Biopharmaceutical Fermentation System Market, by End User
8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Contract Research Organizations
8.4. Food Industry
8.5. Research and Development Institutes

9. Americas Biopharmaceutical Fermentation System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biopharmaceutical Fermentation System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Biopharmaceutical Fermentation System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Becton
13.2. Danaher Corporation
13.3. Dickinson and Company
13.4. F. Hoffmann-La Roche Ltd
13.5. GE Healthcare
13.6. Lonza
13.7. Merck KGaA
13.8. Nova Biomedicals
13.9. Sartorius Stedim
13.10. Thermo Fisher Scientific

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2026
FIGURE 12. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION AND SEPARATION INSTRUMENTS, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION AND SEPARATION INSTRUMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS/FERMENTERS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS/FERMENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA AND CULTURE PREPARATION, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA AND CULTURE PREPARATION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 31. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2026
FIGURE 33. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 35. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD BILLION)
FIGURE 36. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 37. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, 2018-2026 (USD BILLION)
FIGURE 38. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 39. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2026 (USD BILLION)
FIGURE 40. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 41. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 42. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2026
FIGURE 44. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 46. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD BILLION)
FIGURE 47. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 48. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, 2018-2026 (USD BILLION)
FIGURE 49. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 50. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH AND DEVELOPMENT INSTITUTES, 2018-2026 (USD BILLION)
FIGURE 51. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH AND DEVELOPMENT INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 52. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 53. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 55. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 56. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 57. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 58. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 59. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 60. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 61. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 63. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 64. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 65. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 66. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 67. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 68. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 69. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 70. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 71. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 72. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 76. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 77. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 78. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 79. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 80. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 81. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 82. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 83. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 84. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 85. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 86. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 87. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION AND SEPARATION INSTRUMENTS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS/FERMENTERS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA AND CULTURE PREPARATION, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH AND DEVELOPMENT INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 24. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 25. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 26. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 27. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 28. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 29. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 30. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 31. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 32. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 33. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 34. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 35. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 36. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 37. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 38. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 39. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 40. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 41. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 42. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 43. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 44. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 45. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 46. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 47. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 48. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 49. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 50. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 51. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 52. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 53. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 54. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 55. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 56. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 57. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 58. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 59. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 60. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 61. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 62. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 63. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 64. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 65. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 66. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 67. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 68. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 69. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 70. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 71. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 72. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 73. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 74. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 75. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 76. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 77. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 82. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 83. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 84. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 85. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 86. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 87. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 88. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 89. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 90. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 91. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 92. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 93. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 94. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 95. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 96. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 97. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 98. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 99. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 100. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 101. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 102. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 103. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 104. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 105. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 106. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 107. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 108. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 109. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 110. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 111. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 112. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 113. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 114. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: SCORES
TABLE 116. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: BUSINESS STRATEGY
TABLE 117. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 118. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: RANKING
TABLE 119. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 120. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: MERGER & ACQUISITION
TABLE 121. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 122. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 123. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 124. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 125. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Becton
  • Danaher Corporation
  • Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Lonza
  • Merck KGaA
  • Nova Biomedicals
  • Sartorius Stedim
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll